Armata Pharmaceuticals (ARMP) Other Working Capital Changes (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Other Working Capital Changes of -$321000.0 for Q1 2026, down 28.4% on a YoY basis from -$448324.0 in Q1 2025, and down 21.13% sequentially from -$265000.0 in Q4 2025.
Armata Pharmaceuticals (ARMP) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 9 years of Other Working Capital Changes data on file, last reported at -$321000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 28.4% year-over-year to -$321000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (up 63.74% YoY), and the FY2025 full-year result was -$1.0 million, up 79.28% from the prior year.
- Other Working Capital Changes declined to -$321000.0 in Q1 2026, from -$265000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.3 million in Q4 2022 to a low of -$4.9 million in Q4 2023.
- A 5-year average of -$191588.2 and a median of -$539000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 1756.25% in 2022, while the deepest fall reached 775.0% in 2022.
- Tracing ARMP's Other Working Capital Changes over 5 years: stood at $2.2 million in 2022, then tumbled by 270.54% to -$3.7 million in 2023, then surged by 78.59% to -$798000.0 in 2024, then surged by 66.79% to -$265000.0 in 2025, then retreated by 21.13% to -$321000.0 in 2026.
- Business Quant data shows ARMP's Other Working Capital Changes at -$321000.0 in Q1 2026, -$265000.0 in Q4 2025, and -$257000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -948,000.00 |
| Mar 31, 2026 | -948,000.00 |
| Mar 31, 2026 | -948,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Sep 30, 2025 | -1.02 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | -539,000.00 |
| Mar 31, 2025 | -539,000.00 |
| Mar 31, 2025 | -539,000.00 |
| Dec 31, 2024 | -3.01 Mn |
| Dec 31, 2024 | -3.01 Mn |
| Dec 31, 2024 | -3.01 Mn |
| Sep 30, 2024 | 466,000.00 |
| Sep 30, 2024 | 466,000.00 |